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Introduction
• Case study
• Points to consider for discussion
• PCOS information
– Diagnosis
– Management
– Future management
Polly
• Presented to the General Practitioner (GP) aged 13 
years May 2014
– ‘High BMI’
– Gaining weight
• Mum ‘very strict – diet and exercise’
– Menarche – 11 years 
• Regular / heavy
• Started on Logynon - improvement
• ? PCOS
– Did not want an ultrasound
• No other abnormalities – endocrine cause? Referral..
• Bullying
Thoughts / questions / next steps?
Thoughts..
• Oral contraceptive pill
– Decreases 
hyperandrogenism by 
reducing production of 
androgens
De Melo, 2017
NHS, 2019
– Young teenage girl..?
• Body Mass Index 
measurements in 
children
– “Problematic in growing 
youth as great 
divergence is evident in 
bone, muscle, and 
adipose tissue 
development”
Brown, 2017
• ?Stopped growing
• Accurate measurement ?
Referral to Paediatric Endocrinology 
July 2014
History
• Weight increasing since age 
8 years
– Parents separated
• Birth
– 2.3kg at 41 weeks
• Second of 4 children
• Weight problems on Dad’s 
side
– Grandmother – ‘diabetes’
• Still on OCP
– No other medication
On examination
• Overweight
• No other clinical indications
– Acne
– Hirsutism
– Acanthosis
• Genu valgum ‘knock knees’
Next steps?
• Bloods
• Dietician referral
• Pelvic ultrasound
Bloods
Thyroid function tests
Vitamin D levels
Bone profile
Adrenal androgens
Testosterone
SHBG
LH / FSH
Pelvic ultrasound – right ovary
Pelvic ultrasound – left ovary
Pelvic ultrasound - report
• Both ovaries were visualized and appeared 
bulky with multiple microcysts, most of which 
were arranged around the periphery. 
Appearance are suggestive of polycystic 
ovaries
• Right ovary: 34 x 27 x 20mm
• Left ovary: 32 x 19 x 25mm
• Largest follicle is 7mm, in left ovary
Paediatric endocrinology – March 2015
• Pelvic ultrasound reviewed
• Bloods ‘normal’
• Regular periods
– Still heavy
– ‘At least they are regular’
• Mum wanted no further endocrine follow up
• Referral back to GP for dietician referral..
Thoughts?
Gynaecology – July 2015
• Amenorrhea since January
• Abdominal pain 
• Increased BMI
• On examination
– Abdomen soft
– Hirsutism noted
• Investigations
– Bloods
– Ultrasound
• Treatment?
Inofolic sachets
• Combination of Folic Acid and 
Myo-Inositol (MYO)
• MYO
– Involved in the signal of insulin 
from the insulin receptor, so 
important for patients with insulin 
resistance..
– Important role in nuclear and 
cytoplasmic oocyte development
• Helps menstrual cycle 
disturbances
• Reduces obesity
• Reduces hyperandrogenism
Dermatology – July 2017
• History of eczema since puberty
• Increased hirsutism
– Face, arms, legs, back and chest
– Waxes / hair removal creams
• ‘Velvety thickened skin on neck, between the breasts and 
axillae’
– Acanthosis nigricans
• Acne
• No longer on Logynon – but says has lost weight
• No mention of Inofolic sachets
Thoughts?
• Recommends referral to endocrinology
– ? Insulin resistance
– ? Metformin
• Makes referral to laser hair removal clinic
Hirsutism
Acanthosis Nigricans
• Visible marker which 
strongly suggests Insulin 
Resistance
– Higher than normal levels 
of insulin cause the 
darkened growth of skin
– Activates keratinocyte 
receptors, especially IGF-1
• Increased IGF may lead to 
increased keratinocyte and 
dermal fibroblasts
Metformin
• Used widely to treat Type 2 diabetes
• Increase in insulin action at an intracellular locus
– Results in decreased hepatic glucose production
• Stimulates tissue uptake of glucose
• Reduces gastro-intestinal absorption of carbohydrate
– Does not cause hypoglycaemia
– Not associated with weight gain

Paediatric Endocrinology – January 2018
• Oral Glucose Tolerance Test
– Used to measure how the body can process large amounts of sugar
– Oral glucose solution
• 1.75g/kg, up to 75g
– Baseline, 120 minutes
• Glucose 
• Insulin
– Fasting baseline glucose should be below 6.1mmol/L
– Between 6.1 and 7.0 is borderline
– 120 minute sample, glucose is normal if below 10mmol/L
Paediatric Endocrinology – July 2018
Age 17 years
• Androstenedione ↑ 9.3 
nmol/L (2-5.4)
• DHEAS N 4.4umol/L (1.6-
7.8)
• SHBG ↓ 14nmol/L (20-130 
females)
• Testosterone 2.1nmol/L 
(0.2-2.9)
• Liver Function, Fasting 
Lipids 
• HbA1c 24mmol/mol (20-41)
• Periods now regular
• ‘Exercises loads’
• Due laser treatment for 
hirsutism
Thoughts?
DIET
• Skips breakfast
• Snacks on crisps
• Drinks LOTS of juice
0 120
Glucose 4.5mmol/L 5.5
Insulin 44miu/L 310

Role of Adrenal Androgens
• DHEA is the predominant 
androgen
– DHEAS
• Ovary
– 20% of DHEA
– 50% of Androstenedione
– 25% of circulating Testosterone
• Healthy women
– 80% of circulating Testosterone 
is bound to SHBG
• PCOS
– Increased Testosterone
– Elevated DHEAS
– Lower SHBG
Meek et al (2013) The Obstetrician & Gynaecologist
Sex Hormone Binding Globulin
• Made in the liver
• Usually twice as high in women than in men
• Lower levels in PCOS, because of the androgens 
and oestrogens
• Decreases with high insulin levels
• Obese girls likely to have an earlier menarche due 
to the lower SHBG levels
What is PCOS?
• 8 – 13 % of all women
• Increased prevalence as BMI increases
• 2 of the 3 Rotterdam criteria are required for diagnosis
– Polycystic ovaries
• 12 or more follicles measuring 2-9mm in diameter, or increased 
ovarian volume
– Oligomenorrhoea / anovulation
• Reduced periods / failure to release eggs)
– Hyperandrogenism
• Clinically
• Biochemically
What causes it?
• Strong family history
– Genetics?
– Studies still in their
infancy
Management – multidisciplinary approach
• Hyperandrogenism
• Metabolic
– ↑risk of cardiovascular 
disease, T2D, abnormal 
lipids, obstructive sleep 
apnoea
• Reproductive -
– Oral contraceptive pill
• Reduce ovarian androgen 
production by suppressing 
GnRH
• Oestrogens increase the 
SHBG levels
• Psychological
– ↑ depression
– Anxiety
– Psychosexual dysfunction
– Disordered eating
– Feminine identity 
challenged
• Cognitive behavioural
therapy, psychotherapy, 
support groups
Where next for Polly?
• No Metformin
• Discharge back to the General Practitioner, but 
keep under review
• Refer to adult obesity clinic in 6 months
Thoughts?
Conclusion
• PCOS management – complex
• Education
• Support
